“In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors”. 2023. Journal of Pharmaceutical Negative Results, February, 2793-2803. https://doi.org/10.47750/pnr.2023.14.S02.329.